1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Buprenorphine
Trade Name:
Sublocade
Manufacturer/Distributor:
Indivior UK Limited
Imported by Pharma Importing Inc.
Classification:
Partial opioid agonist
ATC Class:
N07BC01 - buprenorphine
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/11/21
Date Marketed in Canada (yyyy/mm/dd):
2019
Presentation:
Injection: 100 mg/0.5 mL. DIN: 02483084
Injection: 300 mg/1.5 mL. DIN: 02483092
Comments:
Long-acting injection of buprenorphine indicated for the management of moderate to severe opioid use disorder in adult patients who have been inducted and clinically stabilized on a transmucosal buprenorphine-containing product. Administered subcutaneously in the abdominal region by a healthcare provider. It will be available by the second half of 2019.
Back to:
Drug Product Listings 
